(Q51594406)
Statements
Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. (English)
1 reference
Mimura K
1 reference
Umeda F
1 reference
Hiramatsu S
1 reference
Taniguchi S
1 reference
Ono Y
1 reference
Nakashima N
1 reference
Kobayashi K
1 reference
Masakado M
1 reference
Sako Y
1 reference
Nawata H
1 reference
1 August 1994
1 reference
11
1 reference
7
1 reference
685-691
1 reference